about
Faulty cardiac repolarization reserve in alternating hemiplegia of childhood broadens the phenotypeIdiopathic restrictive cardiomyopathy in children is caused by mutations in cardiac sarcomere protein genesLong-term outcomes in hypertrophic cardiomyopathy caused by mutations in the cardiac troponin T gene.Feasibility and outcomes of ajmaline provocation testing for Brugada syndrome in children in a specialist paediatric inherited cardiovascular diseases centreDe novo mutations in histone-modifying genes in congenital heart disease.Thioredoxin Reductase 2 (TXNRD2) mutation associated with familial glucocorticoid deficiency (FGD).Semi-supine exercise stress echocardiography in children and adolescents: feasibility and safetyCan atrioventricular septal defects exist with intact septal structures?Cardiac disease in adolescents with delayed diagnosis of vertically acquired HIV infectionHow to use...the paediatric ECG.Nomenclature and systems of classification for cardiomyopathy in children.Echocardiographic reference ranges in older children and adolescents in sub-Saharan Africa.High prevalence of early repolarization in the paediatric relatives of sudden arrhythmic death syndrome victims and in normal controls.Genetic testing for inheritable cardiac channelopathies.Mutations in the cardiac Troponin C gene are a cause of idiopathic dilated cardiomyopathy in childhood.Psychosocial adjustment and quality of life in children undergoing screening in a specialist paediatric hypertrophic cardiomyopathy clinic.Increased left ventricular posterior wall end-diastolic thickness in adolescents with delayed diagnosis of vertically acquired HIV infection.Outcomes after implantable cardioverter-defibrillator treatment in children with hypertrophic cardiomyopathy.Functional analysis of a unique troponin c mutation, GLY159ASP, that causes familial dilated cardiomyopathy, studied in explanted heart muscle.Echocardiographic diagnosis of anomalous origin of the left coronary artery from the right coronary sinus.Prevalence of sequence variants in the RAS-mitogen activated protein kinase signaling pathway in pre-adolescent children with hypertrophic cardiomyopathy.Pigmentary hypertrichosis and non-autoimmune insulin-dependent diabetes mellitus (PHID) syndrome is associated with severe chronic inflammation and cardiomyopathy, and represents a new monogenic autoinflammatory syndrome.Cardiac defects, morbidity and mortality in patients affected by RASopathies. CARNET study results.Data on cardiac defects, morbidity and mortality in patients affected by RASopathies. CARNET study results.Long-term Safety and Efficacy of Mexiletine for Patients With Skeletal Muscle Channelopathies.Racial Variation in Echocardiographic Reference Ranges for Left Chamber Dimensions in Children and Adolescents: A Systematic Review.The Cardiomyopathy Registry of the EURObservational Research Programme of the European Society of Cardiology: baseline data and contemporary management of adult patients with cardiomyopathiesHigh prevalence of echocardiographic abnormalities in older HIV-infected children taking antiretroviral therapySudden Arrhythmic Death Syndrome: Diagnostic Yield of Comprehensive Clinical Evaluation of Pediatric First-Degree RelativesOutcomes following general anaesthesia in children with hypertrophic cardiomyopathyRisk stratification in childhood hypertrophic cardiomyopathyRare diseases hiding in the cardiomyopathy clinic - The importance of seeing and observingB-type natriuretic peptide predicts disease severity in children with hypertrophic cardiomyopathyThe classification concept of the ESC Working Group on myocardial and pericardial diseases for dilated cardiomyopathyObliteration of left superior caval vein draining to the left atrium during spontaneous closure of ventricular septal defectNormalization of echocardiographically derived paediatric cardiac dimensions to body surface area: time for a standardized approachPrevalence of sarcomere protein gene mutations in preadolescent children with hypertrophic cardiomyopathyHypertrophic cardiomyopathy in childrenPacemaker therapy in hypertrophic obstructive cardiomyopathy: still awaiting the evidenceCardiomyopathy in children: importance of aetiology in prognosis
P50
Q27303611-D787E189-A3A0-458D-B5B3-62537B794AA6Q28279508-8B3A4735-F1DB-4F7E-8028-6CE9E0C41F31Q34238575-2035D60B-1476-4522-B756-2EC3AB21D4C7Q34333242-75C8F30D-24C9-4727-99D3-3F78546DFD4FQ34344183-49250A84-663C-42C4-ADF9-73A74ACC489FQ34396448-DFA91E01-AA47-4063-8DB5-22E3367F64A2Q35103685-AE8369DA-F27D-4A94-8DEF-DF0E097C49C3Q35770859-8C954F14-F51E-4B8F-8086-9F0AEE822111Q36555275-582B2784-E44B-4022-9AE1-366641478874Q38155081-5A0C3584-8FFC-4B6E-A08A-2E6FBD4D558DQ38588152-CDD108D9-2647-4145-B2EC-D4080C2A6D49Q38677607-A1F0681C-130C-41CE-8429-727A0704D77FQ38783179-BD50529A-0AE5-4336-A36D-8045AF8340B3Q38831527-4BC3A4B9-3FDA-4C7C-A4F2-DD4D7D1D32BDQ40157913-A8320C03-55A3-4ECB-9868-3A91D72ADE39Q41395024-73338631-47EF-4A44-AB91-C8E7435920A7Q42716811-50E39968-8E3B-4146-AFF0-4B9D1A0A88ADQ42828637-177A5E37-6BFF-4F1D-8900-00F3B51F616FQ43266253-EA64757E-93A7-4C82-9D5B-FC85EC2DA371Q43900475-2D5505CF-2AD6-4914-B4AF-7586D8C2594DQ47759130-EB0D2C2E-F34C-4402-A387-DC4C975BF2B5Q50357096-A5B722B7-B54C-4FF0-A67E-6A2153AA02A4Q50431145-75ABA066-ACA0-4F2F-BF0C-5FF466472B72Q52355029-3D0EF123-F491-49FD-AA56-B13B697B2735Q53247162-8E4A72B0-D2AE-41EE-B816-4B2A736E4478Q55380618-72BC6032-69A4-47EB-B673-2CE5F0EBCD67Q56890936-7098F52E-B6E2-41EE-95AE-E94F77C2E6CEQ57023689-E62D2D65-0BBE-4282-A7BE-30B0EB11363AQ57450981-A1BE5294-6C04-4EC9-BC50-FAE3E3E74CECQ58559983-F79DA9EA-7B10-4203-91BB-6022853848F7Q58565588-E8306F7B-890F-4C2E-B4F7-045A948E8945Q64042081-F82191CE-7B7C-43D0-8544-A513D0BFF0AFQ80175182-5D24A1FE-167C-49DB-990A-17B9731ABD80Q81326479-E9970F24-C17D-476C-9EA3-7C957E90E3F9Q81896604-B8622112-0EBC-4EE4-9B59-EA7103365BB5Q82126541-04E04FAF-2203-4047-B7BC-F75EC791F216Q82327642-C66E2121-2254-479A-9EDA-92C6D08D0DBEQ84146943-D16CBC42-D1E5-400F-AEBE-C59E4AD4A476Q84847407-9D53F70C-6E62-47A4-A794-86A595A0C184Q87382826-370AA5B1-414C-4DB9-8FDC-69167F8197C5
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Juan P Kaski
@ast
Juan P Kaski
@en
Juan P Kaski
@es
Juan P Kaski
@nl
type
label
Juan P Kaski
@ast
Juan P Kaski
@en
Juan P Kaski
@es
Juan P Kaski
@nl
prefLabel
Juan P Kaski
@ast
Juan P Kaski
@en
Juan P Kaski
@es
Juan P Kaski
@nl
P106
P1153
16204898600
P21
P31
P496
0000-0002-0014-9927